Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053593 · ClinicalTrials.gov registry record
Ketostix® and Keto-Diastix® Performance Study
A clinical trial of Urinalysis, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT06053593 is a study of Urinalysis that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 126 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06053593, a study of Urinalysis, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.
Conditions Studied
Interventions
- DEVICE Testing of self collected urine
- DEVICE Labeling Evaluation
- DEVICE Urine Control testing
Study Locations (1)
Maryland
- University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2023-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053593
The ClinicalTrials.gov registry entry for NCT06053593 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinalysis appearing as the primary indexed condition, and to 3 interventions - of which Testing of self collected urine is the first listed.
NCT06053593 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06053593 about?
NCT06053593 is a clinical study titled "Ketostix® and Keto-Diastix® Performance Study". Persons with Diabetes (PWDs), at minimum of (n=120) will successfully collect their urine and test with two Ascensia strip products. The products are: Ketostix and Keto-Diastix.
What is the current status of trial NCT06053593?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2023-07-24. Estimated completion is 2023-11-30.
What conditions does trial NCT06053593 study?
This clinical trial studies the following conditions: Urinalysis.
What interventions are being tested in trial NCT06053593?
The interventions under investigation include: Testing of self collected urine (DEVICE), Labeling Evaluation (DEVICE), Urine Control testing (DEVICE).
Who is sponsoring clinical trial NCT06053593?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053593 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.